Technical Analysis for BCDA - Biocardia Inc.

Grade Last Price % Change Price Change
grade C 5.37 12.58% 0.6000
BCDA closed up 12.58 percent on Tuesday, January 21, 2020, on 1.37 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical BCDA trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction 12.58%
Wide Bands Range Expansion 12.58%
Oversold Stochastic Weakness 12.58%
1,2,3 Pullback Bullish Bullish Swing Setup 38.40%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 38.40%
Narrow Range Bar Range Contraction 38.40%
Older signals for BCDA ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

BioCardia, Inc., formerly Tiger X Medical, Inc., is a clinical-stage regenerative medicine company. The Company is engaged in developing therapeutics for cardiovascular diseases. The Company's lead therapeutic candidate is the CardiAMP Cell Therapy System (CardiAMP). It focuses on the Phase III trial for CardiAMP in ischemic systolic heart failure. The Company also offers CardiALLO Cell Therapy System (CardiALLO), an allogeneic off the shelf mesenchymal stem cell product candidate from other donors. It focuses on the Phase II trial for CardiALLO for the treatment of ischemic systolic heart failure. The Company focuses on various fields of autologous and allogeneic cell-based therapies to manage the lives of patients with cardiovascular conditions. CardiAMP is a therapeutic treatment that includes a companion diagnostic. It consists of a cell potency screening test, a point of care cell processing platform and a biotherapeutic delivery system.
Biotechnology Branches Of Biology Life Sciences Biology Stem Cells Cell Therapy Therapy Regenerative Medicine Cell Biology Heart Failure Cardiovascular Diseases Stem Cell Therapy Regenerative Biomedicine Mesoblast Cell Therapy System Ischemic Systolic Heart Failure Therapeutics For Cardiovascular Diseases Treatment Of Ischemic Systolic Heart Failure

Is BCDA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 17.5
52 Week Low 0.9
Average Volume 5,922
200-Day Moving Average 2.1892
50-Day Moving Average 3.4812
20-Day Moving Average 6.9643
10-Day Moving Average 8.5770
Average True Range 1.8054
ADX 37.18
+DI 37.6449
-DI 33.2123
Chandelier Exit (Long, 3 ATRs ) 12.0838
Chandelier Exit (Short, 3 ATRs ) 6.3662
Upper Bollinger Band 15.5375
Lower Bollinger Band -1.6089
Percent B (%b) 0.41
BandWidth 246.2042
MACD Line 0.9294
MACD Signal Line 1.6863
MACD Histogram -0.7569
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.8158
Resistance 3 (R3) 5.7663 5.5681 5.7415
Resistance 2 (R2) 5.5681 5.4546 5.5929 5.7167
Resistance 1 (R1) 5.4691 5.3845 5.5186 5.5186 5.6920
Pivot Point 5.2709 5.2709 5.2957 5.2957 5.2709
Support 1 (S1) 5.1719 5.1574 5.2214 5.2214 5.0480
Support 2 (S2) 4.9737 5.0873 4.9985 5.0233
Support 3 (S3) 4.8747 4.9737 4.9985
Support 4 (S4) 4.9242